Dose and Rate-Dependent Effects of Adenosine on Atrial Action Potential Duration in Humans

Journal of Interventional Cardiac Electrophysiology

Volumn 1, Issue 1, 1997, Pages 33-37

  Tebbenjohanns, Jürgen ^a,b   Schumacher, Burghard ^a   Pfeiffer, Dietrich ^a   Jung, Werner ^a   Lüderitz, Berndt ^a  

^a UNIVERSITY OF BONN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Adenosine; Atrial fibrillation; Monophasic action potential

Indexed keywords

ADENOSINE; ANTIARRHYTHMIC AGENT;

ACTION POTENTIAL; ADULT; ARTICLE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEART ATRIUM; HEART ATRIUM FUNCTION; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; TACHYCARDIA;

ACTION POTENTIALS; ADENOSINE; ADULT; ANTI-ARRHYTHMIA AGENTS; ATRIAL FUNCTION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TACHYCARDIA;

EID: 0031061178     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009758501195     Document Type: Article

References (29)

1. Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine. Prog Cardiovasc Dis 1989;32:73-97.
2. Clemo HF, Belardinelli L. Effect of adenosine on atrioventricular conduction. I: Site and characterization of adenosine action in the guinea pig atrioventricular node. Circ Res 1986;59:427-436.
3. Clemo HF, Belardinelli L. Effect of adenosine on atrioventricular conduction. II: Modulation of atrioventricular node transmission by adenosine in hypoxic isolated guinea pig hearts. Circ Res 1986;59:437-446.
4. Belhassen B, Pelleg A. Acute management of paroxysmal supraventricular tachycardia: Verapamil, adenosine triphosphate or adenosine? Am J Cardiol 1984;54:225-227
5. Belhassen B, Glick A, Laniado S. Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachcardia. Circulation 1988;77:795-805.
6. Belhassen B, Viskin S. What is the drug of choice for the acute termination of paroxysmal supraventricular tachycardia: Verapamil, adenosine triphosphate or adenosine. PACE 1993;16:1735-1741
7. Camm AJ, Garrat CJ. Adenosine and supraventricular tachycardia. N Engl J Med 1991;5:1621-1629
8. DiMarco JP, Sellers TD, Lerman BB, et al. Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias. J Am Coll Cardiol 1985;6:417-425.
9. DiMarco J, Miles W, Akhtar M, et al. and the Adenosine for PSVT Study Group. Adenosine for paroxysmal supraventricular tachycardia - dose ranging and comparison with verapamil. Ann Intern Med 1990;113:104-110.
10. Garrat C, Linker N, Griffith M, Ward D, Camm AJ. Comparison of adenosine and verapamil for termination of paroxysmal junctional tachycardia. Am J Cardiol 1989;64:1310-1316.
11. Griffith MJ, Ward DE, Linker NJ, Camm AJ. Adenosine in the diagnosis of broad complex tachycardia. Lancet 1988;1:672-675.
12. Hood MA, Smith WM. Adenosine versus verapamil in the treatment of supraventricular tachycardia: A randomized double-crossover trial. Am Heart J 1992;123:1543-1549.
13. McIntosh-Yellin NL, Drew BJ, Scheinman MM. Safety and efficacy of central intravenous bolus administration of adenosine for termination of supraventricular tachycardia. J Am Coll Cardiol 1993;22:741-745.
14. Munoz A, Leenhart A, Sassine A, et al. Therapeutic use of adenosine for terminating spontaneous paroxysmal supraventricular tachycardia. Eur Heart J 1984;5:735-738.
15. Rankin AC, Oldroyd KG, Chong E, Rae AP, Cobbe SM. Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias. Br Heart J 1989;62:195-203
16. Rankin AC, Oldroyd KG, Chong E, Dow JW, Rae AP, Cobbe SM. Adenosine or adenosine triphosphate for supraventricular tachycardias? Comparative double-blind randomized study in patients with spontaneous or inducible arrhythmias. Am Heart J 1990;119:316-323.
17. Rankin AC, Brooks R, Ruskin JN, McGovern BA. Adenosine and the treatment of supraventricular tachycardia. Am J Med 1992;92:655-664.
18. Sharma AD, Klein GJ, Yee R. Intravenous adenosine triphosphate during wide QRS complex tachycardia: Safety, therapeutic efficacy and diagnostic utility. Am J Med 1990;88:337-343.
19. Tebbenjohanns J, Pfeiffer D, Schumacher B, Jung W, Manz M, Lüderitz B. Intravenous adenosine during atrioventricular reentrant tachycardia: Induction of atrial fibrillation with rapid conduction over an accessory pathway. PACE 1995;18:743-746.
20. Belardinelli L, Isenberg G. Isolated atrial myocytes: Adenosine and acetylcholine increase potassium conductance. Am J Physiol 1983;244:H734-H737.
21. Visentin S, Wu SN, Belardinelli L. Adenosine-induced changes in atrial action potential: Contribution of Ca and K currents. Am J Physiol 1990;23:319-326.
22. Franz MR. Long-term recording of monophasic action potentials from human endocardium. Am J Cardiol 1983;51:1621-1634.
23. Belhassen B, Pelleg A, Shoshani D, Laniado S. Atrial fibrillation induced by adenosine triphosphate. Am J Cardiol 1984;53:1405-1406.
24. Rankin AC, Rae AP, Houston A. Acceleration of ventricular response to atrial flutter after intrvenous adenosine. Br Heart J 1993;69:263-265.
25. Slade AKB, Garrat C. Proarrhythmic effect of adenosine in a patient with atrial flutter. Br Heart J 1993;70:91-92
26. Mori T, Moriyama T, Karasawa A. Inhibitory effects of KW-3902, a selective adenosine A1-receptor antagonist, on the adenosine-induced shortening of action potential duration in guinea pig atrial muscles. Jpn J Pharmacol 1993;63:265-268.
27. DiMarco JP, Lerman BB, Kabell G, et al. Adenosine produces different effects on the monophasic action potential in human atrium and ventricle (abstr). J Am Coll Cardiol 1988;11:227A
28. Haines DE, Lerman BB, DiMarco JP. Intravenous adenosine shortens atrial refractoriness in man (abstr.). Circulation 1988;78:11-153.
29. Vokac D, Talajic M, Hadjis T, Dubuc M, Roy D, Nattel S. Electrophysiological effects of adenosine on human monophasic action potentials. J Am Coll Cardiol 1995;-(Suppl):383A